영어 모의고사 (자동 편성)

People routinely seek out information that confirms what they already believe while overlooking or dismissing evidence that ①contradicts those beliefs, a pattern known as confirmation bias. This tendency operates not because individuals are deliberately dishonest, but because the mind finds it cognitively less taxing ②to absorb information that fits an existing framework than to reconstruct that framework from scratch. Investors who believe a particular company will succeed, for instance, tend to interpret ambiguous news about that company favorably, while investors who ③are skeptical of the same company interpret identical news unfavorably, even though both groups are examining the same underlying facts. Social media platforms can intensify this effect by algorithmically presenting users with content similar to what they have previously engaged with, thereby ④narrowing the range of perspectives an individual regularly encounters. Over time, such selective exposure can harden initial impressions into convictions that ⑤feels objectively verified, even though they rest on a systematically filtered sample of evidence.

The immune system produces an almost limitless variety of antibodies, each ①shaped to latch onto one particular molecular target with remarkable specificity. Monoclonal antibody drugs harness this natural precision by cloning a single antibody-producing cell in the laboratory, ②generating an army of identical antibodies built to recognize one target, such as a protein on a cancer cell or a molecule driving an autoimmune disease. Because the antibody binds only to its intended target, these drugs tend to spare healthy tissue far more effectively than traditional chemotherapy, ③which attacks any rapidly dividing cell regardless of whether it is cancerous. Manufacturing monoclonal antibodies remains far more complicated than producing a conventional small-molecule pill, since living cells must ④cultivating in carefully controlled bioreactors for weeks before the antibody can be purified and prepared for use. This complexity keeps monoclonal antibody treatments considerably more expensive than most conventional drugs, a cost that continues ⑤to shape debates over pricing and access.

A cotton plant that manufactures its own insecticide sounds like science fiction, yet it has been ①growing in fields around the world for decades. Scientists achieved this by isolating a gene from a soil bacterium that produces a protein toxic to specific insect pests but harmless to humans, then ②inserting that gene into the plant's own genome so that every cell manufactures the protective protein. Other genetically modified crops carry a gene that allows them ③survive direct exposure to a particular herbicide, letting farmers spray a field to kill weeds without harming the crop growing among them. Supporters point to yield increases and reduced pesticide spraying documented across millions of hectares, while critics worry about weeds and insects ④evolving resistance to these built-in defenses over time, much as bacteria evolve resistance to antibiotics. Regulatory agencies in most countries now require extensive testing before a genetically modified crop reaches the market, ⑤evaluating everything from its nutritional content to its potential effects on nearby ecosystems.

Suppose you meet a quiet, ①gentle man who speaks softly, tends a small garden, and organizes his bookshelf with meticulous care. Asked whether he is more likely a florist or a truck driver, most people ②instinctively choose florist, since his personality matches the stereotype so neatly. This judgment, however, ignores a crucial fact: truck drivers vastly ③trail florists in almost every country, which means that, statistically, he is far more likely to belong to the larger group regardless of how well he fits the flower-shop image. Relying on resemblance to a familiar category rather than on underlying numerical proportions, known among researchers as representativeness, leads people to overlook these base rates almost ④automatically. Even trained professionals, who should know better, often fall into the same trap when a vivid description feels more ⑤convincing than plain statistics.

Behavioral economists have long observed that people tend to feel the pain of losing something more ①intensely than the pleasure of gaining an equivalent amount, a tendency known as loss aversion. Consider an investor who refuses to sell a declining stock, clinging to the hope that its price will eventually ②recover, even when all available evidence indicates that selling and reinvesting elsewhere would be more rational. Such behavior, though it appears ③rational from a purely economic standpoint, becomes understandable once we recognize that the investor is trying to avoid the sharp discomfort associated with realizing a loss. Similarly, consumers often demand a much ④higher price to give up an item they already own than they would be willing to pay to acquire the same item in the first place. As a result, loss aversion frequently pushes individuals toward decisions that ⑤minimize potential regret over losses rather than toward outcomes that maximize their overall welfare.

Policymakers seeking to improve public welfare without restricting individual freedom have increasingly embraced an approach known as nudging, which alters the environment in which choices are made rather than mandating particular outcomes. A nudge preserves every option that was previously available; it simply arranges those options so that the choice deemed most beneficial becomes easier or more visible than the alternatives. Despite ongoing debate over its ethics, governments across many countries have adopted nudge-based programs, reporting outcomes that are frequently ___________ compared with those achieved through traditional regulation or public information campaigns alone.

Marketers have long recognized that perceived scarcity can dramatically increase a product's desirability, even when the item's intrinsic qualities remain entirely unchanged. A retailer who labels a product as "limited edition" or displays a countdown timer beside a discounted offer prompts customers to make hurried purchase decisions they might otherwise postpone or reconsider. Consumers who later reflect calmly on such purchases frequently discover that the item's actual usefulness fell well short of the ___________ they experienced at the moment of decision.

Medieval philosophers told the story of a hungry donkey placed exactly midway between two identical, equally fragrant piles of hay, with no factor whatsoever tipping the balance toward either option. (A) Because the donkey is assumed to be a perfectly rational creature that always chooses the option supported by the strongest reason, it supposedly finds itself with no rational basis for choosing one pile rather than the other. (B) Paralyzed by this perfect symmetry, the donkey starves to death precisely because it can find no reason to move in either direction. (C) Critics of the story point out that real animals, and real humans, rarely face situations of such flawless symmetry, since even a tiny, arbitrary preference is usually enough to break the tie in practice.

That trajectory has continued to accelerate ever since, each new generation of vaccine technology arriving faster than the one before it. When a country physician named Edward Jenner noticed that milkmaids who had caught cowpox seemed immune to smallpox, he set in motion a medical revolution without fully understanding why it worked. ( ① ) For nearly two centuries afterward, vaccine development proceeded largely by trial and error, weakening or killing a pathogen and testing whether the resulting preparation could train the immune system without causing disease itself. ( ② ) This method produced genuine successes, eventually eliminating smallpox worldwide and reducing diseases such as polio and measles. ( ③ ) Each new vaccine, however, still required years of laboratory work with no guarantee of success. ( ④ ) Advances in molecular biology eventually allowed researchers to isolate a single protein from a pathogen's surface rather than using the whole organism, producing vaccines with fewer side effects and a more predictable safety profile. ( ⑤ ) The most recent shift, toward delivering genetic instructions rather than proteins themselves, represents the latest chapter in a story that began with an eighteenth-century doctor's curiosity about a puzzling immunity among dairy workers.

The practical consequence of this precision has been a dramatic acceleration in the pace of genetic research itself. Bacteria have been cutting up invading viral DNA for billions of years, long before any scientist thought to borrow the trick for use in a laboratory. ( ① ) The CRISPR-Cas9 system, as it is now known, relies on a short guide RNA that matches a specific DNA sequence, leading a scissor-like enzyme called Cas9 directly to that exact location in the genome. ( ② ) Once Cas9 arrives at the target site, it slices both strands of the DNA helix, and the cell's own repair machinery rushes in to mend the cut, often introducing a small change in the process. ( ③ ) By supplying the cell with a template during this repair step, scientists can direct that machinery to insert a specific new sequence. ( ④ ) This goes well beyond merely disabling the original gene. ( ⑤ ) What once required years of painstaking work to alter a single gene can now, with a properly designed guide RNA, be accomplished within days.